Zobrazeno 1 - 10
of 837
pro vyhledávání: '"A D Korczyn"'
Autor:
Saar Anis, Achinoam Faust-Socher, Diana Sverdlov, Simon Lassman, Neomi Hezi, Omer Anis, Gil Leor, Amos D. Korczyn, Nir Giladi, Tanya Gurevich
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundWhile cannabis-based medicine is being commonly used in patients with movement disorders, there is a scarcity of publications regarding the effect of cannabis on dystonia. We aimed to describe medical cannabis use in patients with dystonia
Externí odkaz:
https://doaj.org/article/0772cd92325b45fab499abf789bbc51c
Publikováno v:
Behavioural Neurology, Vol 2022 (2022)
Objectives. Assessing the effectiveness and tolerability of medical cannabis (MC) treatment on Gilles de la Tourette syndrome (GTS) patients. Methods. We report on an open-label, prospective study on the effect of MC on adult GTS patients. MC mode of
Externí odkaz:
https://doaj.org/article/fe9537cbe84e45159b40317702993e43
Publikováno v:
BMC Medicine, Vol 17, Iss 1, Pp 1-17 (2019)
Abstract Background The growing body of evidence indicating the heterogeneity of Alzheimer’s disease (AD), coupled with disappointing clinical studies directed at a fit-for-all therapy, suggest that the development of a single magic cure suitable f
Externí odkaz:
https://doaj.org/article/6fb54bb40292415b913c4b2465690452
Autor:
Robert Perneczky, Gerd Kempermann, Amos D. Korczyn, Fiona E. Matthews, M. Arfan Ikram, Nikolaos Scarmeas, Gael Chetelat, Yaakov Stern, Michael Ewers
Publikováno v:
BMC Medicine, Vol 17, Iss 1, Pp 1-15 (2019)
Abstract Background The concept of reserve was established to account for the observation that a given degree of neurodegenerative pathology may result in varying degrees of symptoms in different individuals. There is a large amount of evidence on ep
Externí odkaz:
https://doaj.org/article/c5d48366eccf4195a32ef0f2fde68e25
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Only a few case reports of stroke-like onset of Creutzfeldt-Jakob disease (CJD) have previously been published. We aimed to analyze the neurological, imaging, electroencephalographic (EEG), and laboratory features of patients with this very rare phen
Externí odkaz:
https://doaj.org/article/eab1efc1cac1414b8aee657293e50af4
Autor:
Kurt A. Jellinger, Amos D. Korczyn
Publikováno v:
BMC Medicine, Vol 16, Iss 1, Pp 1-16 (2018)
Abstract Background Dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD), which share many clinical, neurochemical, and morphological features, have been incorporated into DSM-5 as two separate entities of major neurocognitive dis
Externí odkaz:
https://doaj.org/article/0bac0fb2d9f1498295b04276ccb8d70e
Autor:
Régis Bordet, Ralf Ihl, Amos D. Korczyn, Giuseppe Lanza, Jelka Jansa, Robert Hoerr, Alla Guekht
Publikováno v:
BMC Medicine, Vol 15, Iss 1, Pp 1-12 (2017)
Abstract Background Vascular cognitive impairment (VCI) is a complex spectrum encompassing post-stroke cognitive impairment (PSCI) and small vessel disease-related cognitive impairment. Despite the growing health, social, and economic burden of VCI,
Externí odkaz:
https://doaj.org/article/f01390d528c64ec7802789ff9ed7e54a
Licensed Medical Cannabis Use in Gilles de la Tourette Syndrome: A Retrospective Long-term Follow-Up
Publikováno v:
Cannabis and Cannabinoid Research.
Autor:
Yacov Balash, Esther Kahana, Amos D. Korczyn, Meir Wolker, Hadeel Nabal, Emilia Anis, Hanna Rosenmann, Ron Milo
Publikováno v:
Neuroepidemiology.
BACKGROUND: Sporadic Creutzfeldt-Jakob disease (s-CJD) is a rare, fatal neurodegenerative disorder. Familial cases of Creutzfeldt-Jakob disease (f-CJD) due to mutations in the PRNP gene are even rarer around the world; however, in Israel there is a f
Autor:
Einor Ben Assayag, Oren Tene, Amos D. Korczyn, Zahava Solomon, Natan M. Bornstein, Shani Shenhar-Tsarfaty, Estelle Seyman, Dana Niry, Jeremy Molad, Hen Hallevi
Publikováno v:
Stroke. 53:1924-1933
Background: Posttraumatic stress disorder (PTSD) can be triggered by life-threatening medical emergencies, such as stroke. Data suggest that up to 25% of stroke survivors will develop PTSD symptomatology, but little is known about predisposing factor